Kainos Laboratories Stock

Kainos Laboratories Debt 2024

Kainos Laboratories Debt

-2,302.43 JPY

Ticker

4556.T

ISIN

JP3205650009

In 2024, Kainos Laboratories's total debt was -2,302.43 JPY, a 33.81% change from the -1,720.69 JPY total debt recorded in the previous year.

Kainos Laboratories Aktienanalyse

What does Kainos Laboratories do?

Kainos Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Kainos Laboratories's Debt Structure

Kainos Laboratories's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Kainos Laboratories's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Kainos Laboratories’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Kainos Laboratories’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Kainos Laboratories stock

What is the debt of Kainos Laboratories this year?

Kainos Laboratories has a debt level of -2,302.43 JPY this year.

What was the debt of Kainos Laboratories compared to the previous year?

The debt of Kainos Laboratories has increased by 33.81% compared to the previous year increased.

What are the consequences of high debt for investors in Kainos Laboratories?

High debt can pose a risk for investors of Kainos Laboratories, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Kainos Laboratories?

Low debt means that Kainos Laboratories has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Kainos Laboratories affect the company?

An increase in debt of Kainos Laboratories can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Kainos Laboratories affect the company?

A reduction in debt of Kainos Laboratories can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Kainos Laboratories?

Some factors that can influence the debt of Kainos Laboratories include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Kainos Laboratories so important for investors?

The debts of Kainos Laboratories are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Kainos Laboratories take to change the debt?

To change the debt, Kainos Laboratories can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Kainos Laboratories pay?

Over the past 12 months, Kainos Laboratories paid a dividend of 32 JPY . This corresponds to a dividend yield of about 2.72 %. For the coming 12 months, Kainos Laboratories is expected to pay a dividend of 32 JPY.

What is the dividend yield of Kainos Laboratories?

The current dividend yield of Kainos Laboratories is 2.72 %.

When does Kainos Laboratories pay dividends?

Kainos Laboratories pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Kainos Laboratories?

Kainos Laboratories paid dividends every year for the past 16 years.

What is the dividend of Kainos Laboratories?

For the upcoming 12 months, dividends amounting to 32 JPY are expected. This corresponds to a dividend yield of 2.72 %.

In which sector is Kainos Laboratories located?

Kainos Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kainos Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kainos Laboratories from 6/1/2024 amounting to 32 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Kainos Laboratories pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Kainos Laboratories in the year 2023?

In the year 2023, Kainos Laboratories distributed 25 JPY as dividends.

In which currency does Kainos Laboratories pay out the dividend?

The dividends of Kainos Laboratories are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kainos Laboratories

Our stock analysis for Kainos Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kainos Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.